NASDAQ · TLX

Telix Pharmaceuticals Limited financials

$11.34−2.41%

Close Sep 29, 2026 · split-adjusted

Telix Pharmaceuticals Limited has no annual financial statements on file. Funds and some foreign issuers do not file them.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology